PCSK9 and type 2 diabetes mellitus: Subjects who had normal cholesterol levels but had lower plasma levels of PCSK9 and higher levels of LDL-R and CD36 on the surface of their WAT also exhibited higher levels of WAT NLRP3 inflammasome activity and T2D-related hazard indicators (125).